AGC Biologics will commence cell therapy process development and clinical manufacturing services on July 1 at AGC Inc.’s Yokohama Technical Center.

Imagine your immune cells could be modified to attack any kind of cancer. T cell receptor (TCR) therapy has the potential to one day become a universal cancer treatment. But there are risks ...

Keysight's Open RAN Architect (KORA) solutions powered 11 multi-vendor integration test demonstrations in labs across several countries, validating real-world Open RAN deployments. O-RAN Energy ...

Learn how soluble B-cell maturation antigen contributes to the effectiveness of targeted immunotherapies.

Learn how multispecific antibodies can be used for immunotherapy in cancer treatments.

Keysight’s Open RAN Architect (KORA) solutions powered 11 multi-vendor integration test demonstrations in labs across several countries, validating real-world Open RAN deployments.

A team of Memorial Sloan Kettering Cancer Center (MSK) researchers have made an important finding about why genetically engineered immune cells sometimes fail to finish the job when given as a ...

Toddler approved for exclusive stem cell therapy Luca Lisson was diagnosed with a severe brain bleed and Cerebral Palsy when he was born at just 27 weeks old.

CAR T-cell Therapy Market Quick Insights: 🔹The CAR T-cell therapy market surpassed USD 10.39 billion in 2024. 🔹It is projected to surpass USD 128.55 billion by 2034. 🔹The market is expected to ...